SEGMENT REPORTING

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

SEGMENT REPORTING

18. SEGMENT REPORTING

Reportable segments are presented in a manner consistent with the internal reporting provided to the chief operating decision maker (CODM), the Chief Executive Officer of the Company. The CODM allocates resources to and assesses the performance of each segment using information about its revenue and operating income (loss). The Company’s operations involve products and services which are managed separately. Accordingly, it operates in two segments: 1) regenerative medicine products and 2) contract services.

Certain information concerning the Company’s segments is presented in the following tables (in thousands):

	For the Year Ended December 31,
	2021			2020
Net revenues:
Reportable segments:
Regenerative medicine products	$	3,076		$	3,730
Contract services		6,328			6,396
Total net revenues	$	9,404		$	10,126
Net income/(loss):
Reportable segments:
Regenerative medicine products	$	(29,568	)	$	(42,815	)
Contract services		(619	)		(39	)
Total net loss	$	(30,187	)	$	(42,854	)

	December 31, 2021		December 31, 2020
Identifiable assets employed:
Reportable segments:
Regenerative medicine products	$	25,344	$	36,858
Contract services		5,834		8,652
Total assets	$	31,178	$	45,510